Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,304 papers from all fields of science
Search
Sign In
Create Free Account
Myelitis, Paraneoplastic
Known as:
Paraneoplastic Myelitis
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Myelitis, Acute Transverse
Broader (1)
Myelitis, Transverse
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Паранеопластический миелит у пациентки с неходжкинской лимфомой
М. Н. Гусейнова
,
Л. Г. Заславский
,
Е. А. Скорнякова
2020
Corpus ID: 214311432
Objective: description of a clinical case of the development of longitudinally spread transverse myelitis in a young woman…
Expand
2016
2016
Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome
S. Faissner
,
C. Lukas
,
A. Reinacher-Schick
,
A. Tannapfel
,
R. Gold
,
I. Kleiter
Neurology: Neuroimmunology & Neuroinflammation
2016
Corpus ID: 36797973
Finding the underlying etiology of transverse myelitis (TM) can be challenging, as several disorders, including multiple…
Expand
2006
2006
Successful immunosuppressive treatment and long-term follow-up of anti-Ri-associated paraneoplastic myelitis
F. Leypoldt
,
P. Eichhorn
,
C. Saager
,
A. Münchau
,
J. Lewerenz
Journal of Neurology Neurosurgery & Psychiatry
2006
Corpus ID: 18732616
Antineuronal antibody-associated paraneoplastic neurological syndromes (PaNSs) result from tumour-stimulated autoimmune attacks…
Expand
2000
2000
Neoplastic cells in the cerebrospinal fluid in intravascular lymphomatosis
L. Ossege
,
E. Postler
,
B. Pleger
,
K. Müller
,
J. Malin
Journal of Neurology
2000
Corpus ID: 559727
Sirs: Intravascular lymphomatosis (IVL) is a rare malignant disorder with characteristic proliferation of neoplastic lymphoid…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE